A Phase 1/2a Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B-Cell or T-Cell Non-Hodgkin Lymphoma (NHL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01994382

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:43.915021+00:00

Published At

2022-04-05T00:00:00+00:00

Record Updated At

2022-04-05

Results Posted At

2022-04-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Follicular Lymphoma (FL/Indolent NHL)", "Aggressive NHL (a NHL)", "Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)", "T-cell Lymphoma (PTCL and CTCL)", "B-cell Non Hodgkin Lymphoma (NHL)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-04-05"

protocolSection.identificationModule.nctId

"NCT01994382"

protocolSection.identificationModule.officialTitle

"A Phase 1/2a Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B-Cell or T-Cell Non-Hodgkin Lymphoma (NHL)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2022-04-05"

Study condition terms

• Follicular Lymphoma (FL/Indolent NHL) (protocolSection.conditionsModule.conditions)
• Aggressive NHL (a NHL) (protocolSection.conditionsModule.conditions)
• Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) (protocolSection.conditionsModule.conditions)
• T-cell Lymphoma (PTCL and CTCL) (protocolSection.conditionsModule.conditions)
• B-cell Non Hodgkin Lymphoma (NHL) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.